Page 5 of 7
Green Chemistry
DOI: 10.1039/C7GC03812G
o
DMSOꢀd , 25 C, TMS): δ = 10.13 (br, s, 1H, NH), 7.35ꢀ7.38 (m,
Conclusions
6
6
6
0
5
2H, ArH), 7.26ꢀ7.32 (m, 6H, ArH), 7.24 (s, 1H, NH), 7.15ꢀ7.17
(m, 2H, ArH), 6.24 (br, s, 2H, NH ), 4.97 (t, J = 2.4 Hz, 1H, CH),
4.54 (d, J = 3.6 Hz, 1H, CH), 4.41 (s, d, J = 2.0 Hz, 1H, CH);
NMR (100 MHz, DMSOꢀd , 25 C, TMS): δ = 162.7, 161.8,
60.0, 154.4, 154.0, 142.9, 141.8, 137.4, 129.0, 128.8, 128.7,
128.6, 128.4, 128.2, 127.4, 127.2, 126.8, 89.4, 83.0, 53.0; IR
KBr, ν, cm ): 3385, 2920, 1639, 1550, 1474, 1364, 1328, 1104,
45, 770; HRMS (ESI) m/z calcd for C H N O [M + H] :
19 17 5 3
In summary, we have developed a novel threeꢀcomponent
domino reaction for selective synthesis of pyrido[2,3ꢀ
d]pyrimidine derivatives using carbonaceous material as reusable
catalyst with good yields. The cyclization reaction simultaneously
installs two CꢀC bonds and one CꢀN bond to form three chiral
carbon centers with highly selectivity, showing that the procedure
allows the efficient synthesis of diverse 5,6,7,8ꢀ
2
1
3
C
o
6
1
5
ꢀ1
(
+
8
3
64.1404, found: 364.1410.
tetrahydropyrido[2,3ꢀd]pyrimidinꢀ4(3H)ꢀone
derivatives
1
0
selectively. Advantages of this strategy include easily available
starting materials, the relatively mild conditions, convenient oneꢀ
pot operation, recoverable solid acid catalyst, and excellent regioꢀ,
and diastereoselectivity.
General procedure for the synthesis of 6
In a 10ꢀmL reaction vial, 6ꢀaminopyrimidineꢀ2,4(1H,3H)ꢀdione
7
7
8
8
0
5
0
5
5
a or 6ꢀaminoꢀ2ꢀthioxoꢀ2,3ꢀdihydropyrimidinꢀ4(1H)ꢀone 5b (0.5
mmol), (E)ꢀ1ꢀmethylꢀ4ꢀ(2ꢀnitrovinyl)benzene (0.5 mmol), 4ꢀ
methylbenzaldehyde (0.5 mmol), carbonaceous material (Cꢀ
Experimental section
SO H) (10 mg) as well as water (3.0 mL), were added
3
respectively and then capped. The mixture was stirred until TLC
revealed that conversion of the substrates was complete, then, the
reaction mixture was cooled. The resulted precipitate was filtered
and dried along with the catalyst. The crude product was further
1
5
General
All the reagents were commercially available and used without
further purification, unless otherwise stated. IR spectra were
purified
by recrystallization
from hot
ethanol/N,Nꢀ
1
determined on an FTꢀIRꢀTensor 27 spectrometer. HNMR spectra
dimethylformamide to give the pure desired product. 6ꢀaminoꢀ5ꢀ
(2ꢀnitroꢀ1ꢀ(pꢀtolyl)ethyl)pyrimidineꢀ2,4(1H,3H)ꢀdione (6a), white
were recorded on a 400 MHz instrument (Bruker Avance 400
Spectrometer). Chemical shifts (δ) are given in ppm relative to
TMS as the internal reference, with coupling constants (J) in Hz.
o
1
o
2
2
3
0
5
0
solid, mp: >300 C; H NMR (400 MHz, DMSOꢀd , 25 C,
6
TMS): δ = 10.28 (s, 1H), 10.00 (br, s, 1H, NH), 7.29 (d, J = 8.0
Hz, 2H, ArH), 7.04 (d, J = 8.0 Hz, 2H, ArH), 6.36 (br, s, 2H,
NH ), 5.33ꢀ5.39 (m, 1H, CH ), 5.21ꢀ5.26 (m, 1H, CH ), 4.51 (t, J
13
C NMR spectra were recorded at 100 MHz. Chemical shift
2
2
2
were reported in ppm with the internal chloroform signal at 77.0
ppm or dimethyl sulphoxide signal at 39.9 ppm as a standard.
HRMS (ESI) was measured with a Bruker Daltonics APEXII
instrument. Singleꢀcrystal Xꢀray diffraction measurement was
carried out on a Rigaku Saturn CCD diffractometer at 100(2) K 90 7.05 (d, J = 8.0 Hz, 2H, ArH), 6.59 (br, s, 2H, NH ), 5.35ꢀ5.41 (m,
using graphite monochromated Mο Kα radiation (λ = 0.71073 Å).
=
8.0 Hz, 1H, CH), 2.22 (s, 3H, CH ). 6ꢀaminoꢀ5ꢀ(2ꢀnitroꢀ1ꢀ(pꢀ
3
tolyl)ethyl)ꢀ2ꢀthioxoꢀ2,3ꢀdihydropyrimidinꢀ4(1H)ꢀone
yellow solid, mp: >300 C; H NMR (400 MHz, DMSOꢀd , 25 C,
(6b),
o
o
1
6
TMS): δ = 11.70 (br, s, 2H, NH), 7.28 (d, J = 8.0 Hz, 2H, ArH),
2
1H, CH ), 5.23ꢀ5.28 (m, 1H, CH ), 4.55 (t, J = 7.6 Hz, 1H, CH),
2
2
The structure was solved by direct methods and refined by fullꢀ
2.22 (s, 3H, CH
3
).
2
matrix least squares on F using the SHELXTLꢀ97 program
1
6
package. According to literature method, the solid acid (Cꢀ
Acknowledgements
SO H) catalyst was prepared using furaldehyde and
3
We are grateful for the financial support from the Natural Science
Foundation of Zhejiang Province (No. LY16B020007) and the
financial support from the Education Department of Zhejiang
Province (No. Y201636353). We are also grateful to Wenzhou
University and Beijing Normal University for the help of
structure analysis.
hydroxyethylsulfonic acid as substrates.
9
5
General procedure for the synthesis of 4
3
4
4
5
5
5
0
5
0
5
In a 10ꢀmL reaction vial, 2,6ꢀdiaminopyrimidinꢀ4(3H)ꢀone (0.5
mmol), nitroolefin (0.5 mmol), aldehyde (0.5 mmol),
carbonaceous material (CꢀSO H) (10 mg) as well as water (3.0
3
mL), were added respectively and then capped. The mixture was
stirred until TLC revealed that conversion of the substrates was 100 Notes and references
complete, then, the reaction mixture was cooled. The resulted
1
M. Butters, D. Catterick, A. Craig, A. Curzons, D. Dale, A. Gillmore,
S. P. Green, I. Marziano, J. P. Sherlock and W. White, Chem. Rev.,
006, 106, 3002ꢀ3027.
(a) M. Mamaghani and R. H. Nia, J. Heterocyclic Chem., 2017, 54
1700ꢀ1722; (b) K. M. Elattar and B. D. Mert, RSC Adv., 2016,
precipitate was filtered and dried along with the catalyst. The
crude product was further purified by recrystallization from hot
ethanol/N,Nꢀdimethylformamide to give the pure desired product.
2
2
,
,
2
ꢀaminoꢀ6ꢀnitroꢀ5ꢀphenylꢀ7ꢀ(pꢀtolyl)ꢀ5,6,7,8ꢀtetrahydropyrido o
1
05
6
[2,3ꢀd]pyrimidinꢀ4(3H)ꢀone (4a), yellow powder; mp: >300 C;
7
1827ꢀ71851; (c) F. Buron, J. Y. Mérour, M. Akssira, G.
1
o
H NMR (400 MHz, DMSOꢀd , 25 C, TMS): δ = 10.09 (br, s,
6
Guillaumet and S. Routier, Eur. J. Med. Chem., 2015, 95, 76ꢀ95; (d)
G. M. Ziarani, N. H. Nasab and N. Lashgari, RSC Adv., 2016, 6,
38827ꢀ38848.
1
H, NH), 7.34ꢀ7.38 (m, 2H, ArH), 7.25ꢀ7.29 (m, 3H, ArH), 7.17
(s, 1H, NH), 7.11 (d, J = 8.4 Hz, 2H, ArH), 7.04 (d, J = 8.0 Hz,
2
H, ArH), 6.21 (br, s, 2H, NH ), 4.92 (t, J = 2.6 Hz, 1H, CH), 110
3
(a) M. A. Matulenko, C.ꢀH. Lee, M. Jiang, R. R. Frey, M. D. Cowart,
E. K. Bayburt, S. DiDomenico, G. A. Gfesser, A. Gomtsyan, G. Z.
Zheng, J. A. McKie, A. O. Stewart, H. Yu, K. L. Kohlhaas, K. M.
Alexander, S. McGaraughty, C. T. Wismer, J. Mikusa, K. C. Marsh,
R. D. Snyder, M. S. Diehl, E. A. Kowaluk, M. F. Jarvis and S. S.
Bhagwat, Bioorg. Med. Chem., 2005, 13, 3705ꢀ3720; (b) J. A.
Wendt, S. D. Deeter, S. E. Bove, C. S. Knauer, R. M. Brooker, C. E.
AugelliꢀSzafran, R. D. Schwarz, J. J. Kinsora and K. S. Kilgore,
Bioorg. Med. Chem. Lett., 2007, 17, 5396ꢀ5399; (c) H. Gong, H.
Qi, W. Sun, Y. Zhang, D. Jiang, J. Xiao, X. Yang, Y. Wang and S.
Li, Molecules, 2012, 9961ꢀ9970.
2
4.50 (d, J = 3.2 Hz, 1H, CH), 4.39 (d, J = 2.0 Hz, 1H, CH), 2.27
13
o
(s, 3H, CH3); C NMR (100 MHz, DMSOꢀd , 25 C, TMS): δ =
6
1
61.8, 160.0, 154.4, 143.0, 138.0, 134.3, 130.2, 129.4, 129.0,
28.6, 127.8, 127.4, 127.1, 89.4, 83.0, 52.7, 21.1; IR (KBr, ν, cm
: 3499, 3393, 3064, 2901, 1642, 1594, 1545, 1474, 1385, 1322,
ꢀ
1
1
1
1
15
20
)
1285, 1075, 1030, 770, 621; HRMS (ESI) m/z calcd for
+
C H N O [M + H] : 378.1561, found: 378.1565. 2ꢀaminoꢀ6ꢀ
20
19
5
3
nitroꢀ5,7ꢀdiphenylꢀ5,6,7,8ꢀtetrahydropyrido[2,3ꢀd]pyrimidinꢀ
o
1
4
(3H)ꢀone (4k), brown solid, mp: >300 C; H NMR (400 MHz,
This journal is © The Royal Society of Chemistry [year]
Journal Name, [year], [vol], 00–00 |
5